Related Experiment Video
Updated: Jun 12, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Genetic evidence that SMAD2 is not required for gonadal tumor development in inhibin-deficient mice
Saneal Rajanahally1, Julio E Agno, Roopa L Nalam
1Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas 77030, USA.
Background:
Inhibin is a tumor-suppressor and activin antagonist. Inhibin-deficient mice develop gonadal tumors and a cachexia wasting syndrome due to enhanced activin signaling. Because activins signal through SMAD2 and SMAD3 in vitro and loss of SMAD3 attenuates ovarian tumor development in inhibin-deficient females, we sought to determine the role of SMAD2 in the development of ovarian tumors originating from the granulosa cell lineage.
Methods:
Using an inhibin alpha null mouse model and a conditional knockout strategy, double conditional knockout mice of Smad2 and inhibin alpha were generated in the current study. The survival rate and development of gonadal tumors and the accompanying cachexia wasting syndrome were monitored.
Results:
Nearly identical to the controls, the Smad2 and inhibin alpha double knockout mice succumbed to weight loss, aggressive tumor progression, and death. Furthermore, elevated activin levels and activin-induced pathologies in the liver and stomach characteristic of inhibin deficiency were also observed in these mice. Our results indicate that SMAD2 ablation does not protect inhibin-deficient females from the development of ovarian tumors or the cachexia wasting syndrome.
Conclusions:
SMAD2 is not required for mediating tumorigenic signals of activin in ovarian tumor development caused by loss of inhibin.
Insights
SMAD2 does not play a role in ovarian tumor development in inhibin-deficient mice. Ablating SMAD2 did not prevent tumor progression or cachexia wasting syndrome, indicating it is not required for tumorigenic activin signaling.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Inhibin acts as a tumor suppressor and activin antagonist.
- Inhibin deficiency in mice leads to gonadal tumors and cachexia due to increased activin signaling.
- Activin signaling involves SMAD2 and SMAD3; SMAD3 deficiency partially prevents ovarian tumors in inhibin-deficient mice.
Purpose of the Study:
- To investigate the role of SMAD2 in ovarian tumor development in the absence of inhibin.
- To determine if SMAD2 mediates the tumorigenic effects of activin signaling in granulosa cell tumors.
Main Methods:
- Generated double conditional knockout mice lacking both inhibin alpha and SMAD2.
- Monitored survival rates, gonadal tumor development, and cachexia wasting syndrome.
Main Results:
- SMAD2 and inhibin alpha double knockout mice exhibited similar outcomes to controls, including weight loss, tumor progression, and death.
- Elevated activin levels and characteristic pathologies were observed, similar to inhibin-deficient mice.
- SMAD2 ablation did not protect against ovarian tumors or cachexia.
Conclusions:
- SMAD2 is not essential for mediating the tumorigenic signals of activin in ovarian tumors caused by inhibin loss.
- The study indicates SMAD2 is not required for activin-driven ovarian tumorigenesis in this model.
More Related Videos
Related Concept Videos
In-vitro Mutagenesis
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

